Latest Share Chat

Immupharma Share News (IMM)

Immupharma Information

Buy IMM Shares
Add IMM to Watchlist
Add IMM to Alert

Share Price Information for Immupharma (IMM)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 2.21

Bid: 2.21

Ask: 2.29

Change: -0.045 (-1.96%)

Spread: 0.08 (3.62%)

Open: 2.35

High: 2.37

Low: 2.21

Prev. Close: 2.295

Last checked at -

IN BRIEF: ImmuPharma annual loss narrows as R&D spending reduced

Thu, 11th May 2023 11:48

ImmuPharma PLC - London-based drug discovery and development company - Posts no revenue for 2022, compared to GBP118,350 for 2021. Pretax loss narrows to GBP4.5 million from GBP8.9 million a year earlier, as operating loss reduces to GBP3.0 million from GBP6.6 million. Research and development expenditure is GBP2.0 million, down from GBP3.7 million in 2021. Chief Executive Officer Tim McCarthy says: "As a board, we remain focused on bringing our two key late stage clinical assets, Lupuzor for lupus and CIDP closer to the market."

Current stock price: 2.70 pence each, down 6.4% on Thursday in London

12-month change: down 55%

By Xindi Wei, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

More News

20 Dec 2021 11:41

AIM WINNERS & LOSERS: Fundraise lifts ImmuPharma; Proteome wins deal

20 Dec 2021 11:22

ImmuPharma raises £3.55m to fund research pipeline

(Sharecast News) - Specialist drug discovery and development company ImmuPharma announced subscriptions and a placing to raise £3.55m on Monday, to fund its research and development pipeline as well as general working capital.

20 Dec 2021 10:15

ImmuPharma surges after raise at "significant premium" to share price

29 Nov 2021 20:45

TRADING UPDATES: ImmuPharma teams with Imperial; Webis results delayed

29 Nov 2021 13:32

ImmuPharma signs two-year collaboration deal with Imperial College

(Sharecast News) - Specialist drug discovery and development company ImmuPharma announced on Monday that it has signed a two-year collaboration agreement with Imperial College London.

18 Nov 2021 20:53

TRADING UPDATES: Abingdon Health swings to loss; MetalNRG in dispute

18 Nov 2021 15:16

ImmuPharma reports 'significant' progress since restructure

(Sharecast News) - Specialist drug discovery and development company ImmuPharma reported "significant" positive progress on Thursday, following major changes to its board and a restructuring of senior management in August.

1 Oct 2021 11:47

IN BRIEF: Immupharma leaves Euronext Growth Brussels market

29 Sep 2021 20:31

IN BRIEF: ImmuPharma to make cost savings as it simplifies structure

29 Sep 2021 13:22

EARNINGS UPDATES: Pittards swings to profit; Immupharma loss widens

24 Aug 2021 15:08

DIRECTOR DEALINGS: Gamesys, Capital and ActiveOps execs sell shares

12 Aug 2021 14:17

IN BRIEF: Immupharma gets US FDA approval for Lupuzor pre-trial study

12 Aug 2021 13:02

FDA gives ImmuPharma go-ahead for pharmacokinetic study

(Sharecast News) - Specialist drug discovery and development company ImmuPharma said on Thursday that the United States Food and Drug Administration (FDA) has approved the start of the pharmacokinetic study as part of its new, "optimised" international phase 3 trial of 'Lupuzor'.

30 Jul 2021 15:34

EXECUTIVE CHANGES: All change for ImmuPharma board as CEO departs

16 Jul 2021 11:24

Latest Share Chat

Immupharma Share News (IMM)

Share Price Information for Immupharma (IMM)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: ImmuPharma annual loss narrows as R&D spending reduced

Login to your account

Quickpicks are a member only feature

Login to your account